Pain, Addiction, and Opioids - There and Back Again: Lecturettes (4.5 CME)

Product not yet rated

Back to Package

Experts in the field will review the scientific, legislative, and clinical updates from the recent months and examine how these updates will affect the methods providers use to treat their patients. Presenters will also address how the “traditional” pain and addiction provider has changed and how to get providers from diverse backgrounds on the same page for patient care. Participants will learn about the many paradigm-shifting updates to the field through a series of mini-lectures.

Michael Sprintz


Michael Sprintz, D.O. received his medical degree from Midwestern University-Chicago College of Osteopathic Medicine in 1997 and went on to a residency in Anesthesiology at Johns Hopkins Hospital. He left Hopkins to do post-doctoral research in biomedical nanotechnology before returning to complete his anesthesia training at University of South Florida. Dr. Sprintz completed a Pain Medicine Fellowship at MD Anderson Cancer Center in 2012 and is triple-board-certified in Anesthesiology, Addiction Medicine, and Pain Medicine. Dr. Sprintz is the Past-President of the Texas Society of Addiction Medicine, as well as the CEO of iLumHealth, a software company developing world-class products to prevent abuse and diversion of prescription drugs, educate providers, and employ rational solutions that save lives and create value. In addition, Dr. Sprintz is the Founder and Chief Medical Officer of the Sprintz Center for Pain and Dependency, an ultra-specialized outpatient center for the comprehensive treatment of chronic pain, dependency and addiction, located in The Woodlands, TX.

Andrea G. Barthwell


Andrea Grubb Barthwell, M.D., F.A.S.A.M., is the founder and Chief Executive Officer of the global health care and policy-consulting firm EMGlobal LLC and Director at Two Dreams Outer Banks Treatment Center. President George W. Bush nominated Dr. Barthwell in December 2001 to serve as Deputy Director for Demand Reduction in the Office of National Drug Control Policy (ONDCP). The United States Senate confirmed her nomination on January 28, 2002. As a member of the President's sub-cabinet, Dr. Barthwell was a principal advisor in the Executive Office of the President (EOP) on policies aimed at reducing the demand for illicit drugs. Dr. Barthwell received a Bachelor of Arts degree in Psychology from Wesleyan University, where she serves on the Board of Trustees, and a Doctor of Medicine from the University of Michigan Medical School. Following post-graduate training at the University of Chicago and Northwestern University Medical Center, she began her practice in the Chicago area. Dr. Barthwell served as President of the Encounter Medical Group (EMG, an affiliate of EMGlobal), was a founding member of the Chicago Area AIDS Task Force, hosted a weekly local cable show on AIDS, and is a past president of the American Society of Addiction Medicine. In 2003, Dr. Barthwell received the Betty Ford Award, given by the Association for Medical Education and Research in Substance Abuse. In 1997, Dr. Barthwell's peers named her one of the "Best Doctors in America" in addiction medicine.

Alexander Y. Walley


Alexander Y. Walley, M.D., M.Sc., is an Associate Professor of Medicine at Boston University School of Medicine, a general internist and addiction medicine specialist at Boston Medical Center. He is the director of the Addiction Medicine Fellowship program and founded the Inpatient Addiction Consult Service at Boston Medical Center. He does clinical and research-related work on the medical complications of substance use, specifically HIV and overdose. He provides primary care and office-based buprenorphine treatment for HIV patients and methadone maintenance treatment. He is the medical director for the Massachusetts Department of Public Health’s Opioid Overdose Prevention Pilot Program. 

William Jacobs


William S. Jacobs, M.D, Associate Professor, Medical College of Georgia. is a national clinical expert, triple board certified in Anesthesiology, Pain Medicine, and Addiction Medicine physician. A Magna Cum Laude University of Georgia undergraduate and graduate of the Medical College of Georgia, Dr. Jacobs did his Anesthesiology Residency at the University of Alabama-Birmingham. He had a 13 year career as a private practitioner in anesthesiology and pain management before matriculating to UF for his Addiction Medicine Fellowship.

Dr. Jacobs has been a national expert, testifying on Capitol Hill on MDMA and prescription misuse and abuse. He was a medical and scientific Consultant to the US Senate as well as the Department of Labor. Dr Jacobs has also testified and consulted for the DEA on safe prescribing of narcotic drugs and the model of ideal treatment programs. Dr. Jacobs has been the Medical Director of non-profit, profit, and academic chemical dependency and dual diagnosis programs. After his promotion to Associate Professor, he left academia and started NexStep Integrated Pain Care Inc., a model outpatient program for the treatment of patients with both chronic pain and addiction disorders. He returned to the University of Florida full time as Associate Professor in Psychiatry and Addiction Medicine: Co-Chief of Pain Medicine in 2012.

Dr. Jacobs is the author of peer reviewed scientific papers, abstracts, textbook chapters including the ASAM and APA definitive substance use volumes, and practice guidelines including highly cited studies on mitigating opioid abuse in chronic pain treatment, physician recovery, naltrexone, urine drug testing, and body mass index and alcohol use.

Dr Jacobs has returned home to Georgia to become the first Chief of Addiction Medicine at The Medical College of Georgia He is also Medical Director of The Bluff Plantation as well as Chief Medical Officer for Georgia Detox & Recovery.

Mark Pew

Mark Pew, Senior Vice President of PRIUM, has more than 35 years of experience in the property and casualty, healthcare and technology industries.  He created PRIUM’s Medical Intervention Program in 2003, Intervention Triage in 2010, Texas Drug Formulary turnkey solution in 2011, Centers with Standards in 2012, and TaperRx in 2014.

Mark is a popular speaker at workers’ compensation conferences around the country as well as individual continuing education venues.  He has spoken at the National Workers’ Compensation and Disability Conference, National Rx Drug Abuse & Heroin Summit, and 56 other national or statewide gatherings around the country. From March 2012 thru January 2017, Mark presented educational content 392 times to 26,873 people in 40 states + DC, including 16 national webinars.
A frequent media source for stories on pharmacy, chronic pain and marijuana in workers’ compensation, Mark is a regular article contributor to Claim Management Magazine, Workers’ Compensation Magazine, Insurance Thought Leader and LexisNexus. He also publishes thought-provoking original-content on LinkedIn and @RxProfessor.
Mark was named one of the “Best Blogs of 2016” by and received the prestigious Magna Comp Laude award at WorkCompCentral’s 2016 Comp Laude Awards Gala.
Mark serves on the Medical Issues Committee of the International Association of Industrial Accident Boards and Commissions (IAIABC), the Workers’ Compensation Committee for the Self-Insurance Institute of America (SIIA), and the Pharmacy Group for CompSense in California (chairman) and New York. In addition, he serves as a technical advisor to multiple jurisdictions on subjects such as drug formularies, treatment guidelines and medicinal use of cannabis.
To know more about who Mark is and why he does what he does, read “Thursday Thought Leaders” at

R. Corey Waller


R. Corey Waller, MD, MS, FACEP, DFASAM, is an addiction, pain and emergency medicine specialist. Dr. Waller earned his bachelor's degree in biology and his master's degree in neuromolecular biology at Southwest Texas State University in San Marcos, Texas. He earned his medical degree at University of Texas Medical School in San Antonio. Dr. Waller completed his emergency medicine residency at Thomas Jefferson University in Philadelphia. He is board certified and fellowship trained in addiction medicine.

Andrew J. Kolodny


Dr. Andrew Kolodny is the Co-Director of the Opioid Policy Research Colloborative at Brandeis University's Heller School.  His primary area of focus is the prescription opioid and heroin crisis devastating families and communities across the country. He is also the executive director of Physicians for Responsible Opioid Prescribing, an organization with a mission to reduce morbidity and mortality caused by overprescribing of opioid analgesics.

Dr. Kolodny previously served as Chief Medical Officer for Phoenix House, a national non profit addiction treatment agency and Chair of Psychiatry at Maimonides Medical Center in New York City. He has a long-standing interest in public health. He began his career working for the New York City Department of Health and Mental Hygiene in the Office of the Executive Deputy Commissioner. For New York City, he helped develop and implement multiple programs to improve the health of New Yorkers and save lives, including city-wide buprenorphine programs, naloxone overdose prevention programs and emergency room-based screening, brief intervention and referral to treatment (SBIRT) programs for drug and alcohol misuse.

Mark A. Weiner


Dr. Weiner received his undergraduate degree (B.S. Psychology) at the University of Michigan, Ann Arbor. He earned his medical degree at Cornell University Medical College in New York City. He completed his internship and residency in Internal Medicine at Northwestern University McGaw Medical Campus in Chicago, Illinois. He is Board Certified in Internal Medicine and Addiction Medicine. Since 2008, Dr. Weiner has worked at Pain Recovery Solutions in Ann Arbor, Michigan practicing full time Addiction Medicine and Pain Medicine. He is the Section Head of Addiction Medicine at Saint Joseph Mercy Hospital - Ann Arbor. He has participated in planning the ASAM preconfernece, Common Threads: Pain and Addiction, since 2011 and is the current vice chair. He also is a member of the ASAM Annual Meeting planning committee since 2014 and is an editor on the up-and-coming ASAM Pain and Addiction Handbook.

Melvin I. Pohl


Mel Pohl, MD, FASAM is a Board Certified Family Practitioner. He is the Medical Director of Las Vegas Recovery Center (LVRC). Dr. Pohl was a major force in developing LVRCs Chronic Pain Recovery Program. He is certified by the American Board of Addiction Medicine (ABAM), and a Fellow of the American Society of Addiction Medicine (ASAM). Dr. Pohl is a Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Nevada School of Medicine. He is a nationally known public speaker and co-author of Pain Recovery: How to Find Balance and Reduce Suffering from Chronic Pain (Central Recovery Press, 2009); Pain Recovery for Families: How to Find Balance When Someone Elses Chronic Pain Becomes Your Problem Too (Central Recovery Press, 2010). Dr. Pohl is the author of A Day without Pain (Central Recovery Press, 2008), which won a silver medal from Independent Publisher Book Award in May 2009. His new book writtten with Kathy Ketcham The Pain Antidote: The Proven Program to Help You Stop Suffering From Chronic Pain, Avoid Addiction to Painkillers - and Reclaim Your Life (DeCapo) will be out May 2015 . Las Vegas Recovery Center- Salary- Medical Director


The Pain Problem for Addiction Specialists
Open to view video.
Open to view video. As the pendulum swings back in the opioid abuse epidemic, the number of pain patients being referred to addiction specialists for evaluation and treatment will continue to escalate. You need new tools to deal with these complex patients at the intersection of medical and behavioral health. Like it or not, you are going to see these patients, so you need to understand what you're dealing with and have some effective strategies and tools to deliver appropriate and safe care. This presentation will help you see yourself and your patients in a new light, while giving you some of the fundamentals when the inevitable question arises, "...but how are you gonna treat my pain?"
The Impact of State Cannabis Legislation on Public Health and Safety for Health Care Providers
Open to view video.
Open to view video. As of 1/2017, 28 states and DC have legislation which, as a general rule, provides an affirmative defense for use of cannabis by individuals with certain medical diagnoses. As of 1/2017, eight (8) states and DC have a variety of legal protections for cannabis-use for its intoxicating effects. Changing views on availability, including forms, and acceptance of use may have or will have an effect on public health, law, and policy.
Optimizing Safety in People with Opioid Use Disorder
Open to view video.
Open to view video. At the end of this session, learners should be able to: 1. Define harm reduction and apply it to public health 2. Explain the rationale and evidence for: a. needle syringe access b. supervised injection facilities and c. naloxone rescue kits for overdose prevention
Heroin and Synthetic Opioids
Open to view video.
Open to view video. During this presentation attendees will receive an update on the recent and current status of Heroin and Synthetic Opioids nationally and internationally.
Workers' Compensation Evolving Perspective on Interdisciplinary Management of SUD and Pain
Open to view video.
Open to view video. This session will discuss types of treatment covered in workers comp cases and interdisciplinary approaches to functional recovery.
Audience Q&A - Part 1
Open to view video.
Open to view video. This session was recorded on 4/6/2017 in New Orleans, LA.
Re-framing the Conversation for a Pain Specialist
Open to view video.
Open to view video. This session will review what pain specialists treating patients with pain and addiction need to know.
Making a U-turn: Clinical Applications of Opioid Guidelines
Open to view video.
Open to view video. Dr. Kolodny will discuss changes in opioid prescribing recommendations over the past 20 years. His presentation will include a discussion of pharmaceutical industry bias in prescriber education; the association between increased opioid prescribing and rising rates of opioid addiction; the FDA's Opioid REMS program, the CDC guideline on opioid use for chronic pain; professional society opioid prescribing recommendations; and the recently released Veterans Affairs opioid guideline.
Management Options for Patients on High Dose Opioids and Benzodiazepines
Open to view video.
Open to view video. In this presentation, we will look at the clinical challenges that arise when treating patients on high dose opiates or sedatives. We will also discuss the factors that lead to frustration for health care providers when treating this population and how this frustration might lead to poor clinical decision making.
Actually Implementing Non-pharma Behavioral Interventions
Open to view video.
Open to view video. This session will examine new research and science behind non-pharmacological approaches to managing pain.
Audience Q&A - Part 2
Open to view video.
Open to view video. This session was recorded on 4/6/2017 in New Orleans, LA.
CME Quiz
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Complete the quiz to claim CME.
CME Credit and Certificate
Up to 4.50 medical credits available  |  Certificate available
Up to 4.50 medical credits available  |  Certificate available 4.5 CME Credits